加速全球化布局:英硅智能联手康哲药业、信达生物88.5亿美元出海、复方丹参滴丸美国梦碎

中国粉体网
Feb 10

中国粉体网讯1、英硅智能:与康哲药业达成药物研发战略合作2月10日英硅智能发布公告,其已与康哲药业达成药物研发战略合作。双方聚焦中枢神经系统及自身免疫疾病领域,将开展一系列由AI赋能的创新药物研发合作。合作将结合英硅智能已验证的AI平台与AI赋能创新药研发能力,以及康哲药业经验丰富的研发团队和对疾病领域的深度认知,共同推进不少于2个研发项目开发。2、诺诚健华宣布ICP-538成为中国首款获批临床的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10